648. Effect of cariprazine on psychotic symptoms and impulsivity in first-episode psychosis with comorbid cannabis use: a case series from early intervention services in Greece
E Ntouros, E I Nazlidou, D Partsanaki, S Dimitrakopoulos, V I Spatharas, V P Bozikas, V M Mavreas · 2026
Read 648. Effect of cariprazine on psychotic symptoms and impulsivity in first-episode psychosis with comorbid cannabis use: a case series from early intervention services in Greece by E Ntouros, E I Nazlidou, D Partsanaki, S Dimitrakopoulos, V I Spatharas, V P Bozikas, V M Mavreas (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13556406.txt.
Description
E Ntouros and co-authors report a 2026 case series from early intervention services in Greece. Patients had a first episode of psychosis and also used cannabis. Each patient was treated with cariprazine, a drug that acts on dopamine receptors.
Cannabis use is common in first-episode psychosis and is linked to worse outcomes. Relapse, hospital stays, and poor adherence all rise, and rash acts are more common. The team tracked psychotic symptoms and impulsivity during care with the drug. Past hints suggest the drug may help beyond core symptoms. Readers see early clinical notes on a hard pairing: new psychosis plus ongoing cannabis use.
Catalog record
| CREATOR | E Ntouros, E I Nazlidou, D Partsanaki, S Dimitrakopoulos, V I Spatharas, V P Bozikas, V M Mavreas |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |